Cargando…

Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide

Triple-negative breast cancer (TNBC) is a highly metastatic and aggressive disease with limited treatment options. Recently, the combination of the immune checkpoint inhibitor (ICI) atezolizumab (anti-PD-L1) with nab-paclitaxel was approved following a clinical trial that showed response rates in at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirando, Adam C., Patil, Akash, Rafie, Christine I., Christmas, Brian J., Pandey, Niranjan B., Stearns, Vered, Jaffee, Elizabeth M., Roussos Torres, Evanthia T., Popel, Aleksander S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458646/ https://www.ncbi.nlm.nih.gov/pubmed/32923118 http://dx.doi.org/10.1080/2162402X.2020.1760685

Ejemplares similares

Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors
por: Wang, Hanwen, et al.
Publicado: (2020)

Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth
por: Furukawa, Natsuki, et al.
Publicado: (2023)

Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis
por: Jin, Kideok, et al.
Publicado: (2017)

Suppression of Ocular Vascular Inflammation through Peptide-Mediated Activation of Angiopoietin-Tie2 Signaling
por: Mirando, Adam C., et al.
Publicado: (2020)

Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer
por: Mi, Haoyang, et al.
Publicado: (2020)

Anti-angiogenic collagen IV-derived peptide target engagement with α(v)β(3) and α(5)β(1) in ocular neovascularization models
por: Lima e Silva, Raquel, et al.
Publicado: (2023)

Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma
por: Barbhuiya, Mustafa A., et al.
Publicado: (2017)

Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis
por: Jin, Kideok, et al.
Publicado: (2018)

Lymphatic endothelial cells support tumor growth in breast cancer
por: Lee, Esak, et al.
Publicado: (2014)

Immunoactivating the tumor microenvironment enhances immunotherapy as predicted by integrative computational model
por: Popel, Aleksander S.
Publicado: (2020)

Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers
por: Mi, Haoyang, et al.
Publicado: (2022)

The Potential of PSMA as a Vascular Target in TNBC
por: Heesch, Amelie, et al.
Publicado: (2023)

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma
por: Jafarnejad, Mohammad, et al.
Publicado: (2019)

Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells
por: Norton, Kerri-Ann, et al.
Publicado: (2014)

Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes
por: Fertig, Elana J., et al.
Publicado: (2015)

An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia
por: Norton, Kerri-Ann, et al.
Publicado: (2017)

Multiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment
por: Norton, Kerri-Ann, et al.
Publicado: (2019)

Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
por: Chaudhuri, Aiswarya, et al.
Publicado: (2023)

Computational Model of MicroRNA Control of HIF-VEGF Pathway: Insights into the Pathophysiology of Ischemic Vascular Disease and Cancer
por: Zhao, Chen, et al.
Publicado: (2015)

A mechanistic integrative computational model of macrophage polarization: Implications in human pathophysiology
por: Zhao, Chen, et al.
Publicado: (2019)

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

The Tie2 signaling pathway in retinal vascular diseases: a novel therapeutic target in the eye
por: Nguyen, Quan Dong, et al.
Publicado: (2020)

Mapping the Tumor Microenvironment in TNBC and Deep Exploration for M1 Macrophages-Associated Prognostic Genes
por: Xu, Baojin, et al.
Publicado: (2022)

Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
por: Lee, Esak, et al.
Publicado: (2014)

Multi-Scale Spatial Analysis of the Tumor Microenvironment Reveals Features of Cabozantinib and Nivolumab Efficacy in Hepatocellular Carcinoma
por: Mi, Haoyang, et al.
Publicado: (2022)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

Inhibition of breast cancer growth and metastasis by a biomimetic peptide
por: Lee, Esak, et al.
Publicado: (2014)

Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020)

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021)

Computational Model of Vascular Endothelial Growth Factor Spatial Distribution in Muscle and Pro-Angiogenic Cell Therapy
por: Mac Gabhann, Feilim, et al.
Publicado: (2006)

TNBC invasion: downstream of STAT3
por: Jackson, James G., et al.
Publicado: (2017)

Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC)
por: Zylla, Jessica L. S., et al.
Publicado: (2022)

Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer
por: Sammons, Sarah, et al.
Publicado: (2023)

Vascular normalization: a strategy to recondition the tumor immune microenvironment
por: Huang, Yuhui, et al.
Publicado: (2013)

Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment
por: Zhang, Yue, et al.
Publicado: (2023)

A Comparative Analysis of the Murine Thymic Microenvironment in Normal, Autoimmune, and Immunodeficiency States
por: Takeoka, Yuichi, et al.
Publicado: (1997)

Aptamer-Based Strategies to Boost Immunotherapy in TNBC
por: Agnello, Lisa, et al.
Publicado: (2023)

Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection
por: Zhang, Yu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fo5hcpuj4gp6jj1tfd3tl3t25r